Key facts
- Blackbird Health’s last known valuation is $58.0M (Feb 2024).
- It has raised $22.8M across 1 recorded rounds; the latest was Early Stage VC ($22.8M) in Jan 2024.
- Notable investors include Oxeon Partners, Define Ventures, Frist Cressey Ventures, GreyMatter (US), Hopelab.
- Blackbird Health has filed 1 Form D with the SEC, most recently Feb 2024 ($22.8M sold to 27 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Blackbird Health
Funding rounds
1 roundsAbout Blackbird Health
Provider of pediatric and young adult mental and behavioral health services intended to deliver accessible, multidisciplinary care for developmental, emotional, and behavioral challenges. The company combines whole-child assessments, evidence-based therapy, psychological and neurodevelopmental evaluations, and medication management across virtual and in-person settings, enabling families of children and young adults to receive coordinated, specialist-led support for conditions such as anxiety, autism, trauma, and behavioral issues with a focus on measurable, lasting outcomes and reduced reliance on medication.
- Sector
- Healthcare
- HQ
- Allentown, PA, United States
- Founded
- 2015
- Employees
- 120
- Website
- blackbirdhealth.com/
- Ownership
- Privately Held (backing)
Blackbird Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blackbird Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blackbird Health in its N-PORT filings yet. We sweep new filings monthly.